Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Deferred Taxes (2016 - 2025)

Mimedx's Deferred Taxes history spans 6 years, with the latest figure at -$2.1 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 11.97% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$8.7 million, up 30.16%, while the annual FY2025 figure was -$8.7 million, 30.16% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$2.1 million at Mimedx, up from -$5.8 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $37.8 million in Q4 2023 and bottomed at -$5.8 million in Q3 2025.
  • The 3-year median for Deferred Taxes is -$2.1 million (2025), against an average of $1.8 million.
  • The largest annual shift saw Deferred Taxes tumbled 106.16% in 2024 before it surged 94.59% in 2025.
  • A 3-year view of Deferred Taxes shows it stood at $37.8 million in 2023, then crashed by 106.16% to -$2.3 million in 2024, then grew by 11.97% to -$2.1 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Deferred Taxes are -$2.1 million (Q4 2025), -$5.8 million (Q3 2025), and -$287000.0 (Q2 2025).